Abstract 10 Table 1
EndpointsGroup A
0–2 Days (N=120)
Group B
2–4 Days (N=157)
Group C
>4 Days (N=45)
Log Rank
P-Value
Pre-Transplant
FEV1/FVC<70%
11.7%(14/120)19.1%(33/157)17.8%(8/45)P=0.052
Group A vs. B
ECMO DuringVentilation2.5%(3/120)1.9%(3/157)28.9%(13/45)P<0.05
Group A vs. C
Group B vs. C
1-Year Survival92.0%93.0%66.6%***<0.001
1-Year Freedomfrom Any Treated Rejection82.0%86.9%77.9%0.313
  • *p<0.05 compared to Group A (0–2 Days).

  • **p<0.05 compared to Group B (2–4 Days).